Pediatrix Medical Group (NYSE:MD) Posts Quarterly Earnings Results, Beats Estimates By $0.12 EPS

Pediatrix Medical Group (NYSE:MD) posted its quarterly earnings data on Thursday. The company reported $0.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.37 by $0.12, Zacks reports. Pediatrix Medical Group had a negative net margin of 12.65% and a positive return on equity of 12.79%.

Pediatrix Medical Group Price Performance

NYSE:MD traded up $2.76 on Thursday, reaching $16.87. The stock had a trading volume of 258,373 shares, compared to its average volume of 476,892. The company has a market capitalization of $1.45 billion, a P/E ratio of -5.49, a price-to-earnings-growth ratio of 1.44 and a beta of 1.57. Pediatrix Medical Group has a 1-year low of $6.62 and a 1-year high of $16.72. The company has a quick ratio of 1.42, a current ratio of 1.42 and a debt-to-equity ratio of 0.83. The stock has a fifty day moving average price of $13.80 and a 200-day moving average price of $12.88.

Analyst Ratings Changes

A number of analysts recently weighed in on MD shares. Deutsche Bank Aktiengesellschaft upped their target price on shares of Pediatrix Medical Group from $9.00 to $15.00 and gave the company a “hold” rating in a research note on Monday, November 4th. Jefferies Financial Group upped their target price on shares of Pediatrix Medical Group from $14.00 to $18.00 and gave the company a “buy” rating in a research note on Tuesday, November 5th. Truist Financial lowered their target price on shares of Pediatrix Medical Group from $16.00 to $15.00 and set a “hold” rating on the stock in a research note on Monday, January 6th. UBS Group upped their target price on shares of Pediatrix Medical Group from $10.50 to $16.50 and gave the company a “neutral” rating in a research note on Tuesday, November 5th. Finally, Mizuho upped their target price on shares of Pediatrix Medical Group from $13.00 to $15.00 and gave the company a “neutral” rating in a research note on Tuesday, November 19th. Four investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $16.25.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.